Involvement of reactive nitrogen oxides for acquisition of metastatic properties of benign tumors in a model of inflammation-based tumor progression

Nitric Oxide - Biology and Chemistry

Volumn 14, Issue 2 SPEC. ISS., 2006, Pages 122-129

  Okada, Futoshi ^a   Tazawa, Hiroshi ^b   Kobayashi, Tokushige ^c   Kobayashi, Masanobu ^c,d   Hosokawa, Masuo ^e  

^a YAMAGATA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c Institute for Genetic Medicine   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Fibrosarcoma cells; Inflammation; Metastasis; Reactive nitrogen oxides; Tumor progression

Indexed keywords

3 NITROTYROSINE; 8 HYDROXY 2 DEOXYGUANOSINE; AMINOGUANIDINE; GELATIN SPONGE; GUANOSINE DERIVATIVE; NITRIC OXIDE SYNTHASE; NITROGEN OXIDE; REACTIVE NITROGEN SPECIES; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BENIGN TUMOR; CANCER TRANSPLANTATION; CELL LINE; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; METASTASIS POTENTIAL; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALIA; MURINAE;

EID: 31544469761     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2005.06.009     Document Type: Article

References (50)

1. H. Ohshima Genetic and epigenetic damage induced by reactive species: implications in carcinogenesis Toxicol. Lett. 140-141 2003 99 104
2. H. Oshima, and H. Bartsch Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis Mutat. Res. 305 1994 253 264
3. C.R. Kapadia Oxides, anions and other matters gastrointestinal-1996-a perspective J. Clin. Gastroenterol. 24 1997 133 139
4. F. Okada Inflammation and free radicals in tumor development and progression Redox. Rep. 7 2002 357 368
5. G.R. Stark, I.M. Kerr, B.R. Williams, R.H. Silverman, and R.D. Schreiber How cells respond to interferons Annu. Rev. Biochem. 67 1998 227 264
6. A.K. Nussler, D.A. Geller, M.A. Sweetland, M. Di Silvio, T.R. Billiar, J.B. Madariaga, R.L. Simmons, and J.R. Lancaster Jr. Induction of nitric oxide synthase and its reactions in cultured human and rat hepatocytes stimulated with cytokines and LPS Biochem. Biophys. Res. Commun. 194 1993 826 835
7. D.C. Jenkins Roles of nitric oxide in tumor growth Proc. Natl. Acad. Sci. USA 92 1995 4392 4396
8. P. Edwards, J.C. Cendan, D.B. Topping, L.L. Moldawer, S. MacKay, E.M. Copeland III, and D.S. Lind Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo J. Surg. Res. 63 1996 49 52
9. Z. Dong, A.H. Staroselsky, X. Qi, K. Xie, and I.J. Fidler Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells Cancer Res. 54 1994 789 793
10. L.K. Su, K.W. Kinzler, B. Vogelstein, A.C. Preisinger, A.R. Moser, C. Luongo, K.A. Gould, and W.F. Dove Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene Science 256 1992 668 670
11. D.J. Scott, M.A. Hull, E.J. Cartwright, W.K. Lam, A. Tisbury, R. Poulsom, A.F. Markham, C. Bonifer, and P.L. Coletta Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the Apc(Min/+) mouse Gastroenterology 121 2001 889 899
12. B. Ahn, and H. Ohshima Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production Cancer Res. 61 2001 8357 8360
13. Q. Shi, Q. Xiong, B. Wang, X. Le, N.A. Khan, and K. Xie Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis Cancer Res. 60 2000 2579 2583
14. F. Okada, M. Hosokawa, J.-I. Hamada, J. Hasegawa, M. Kato, M. Mizutani, J. Ren, N. Takeichi, and H. Kobayashi Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge) Br. J. Cancer 66 1992 635 639
15. H. Tazawa, F. Okada, T. Kobayashi, M. Tada, Y. Mori, Y. Une, F. Sendo, M. Kobayashi, and M. Hosokawa Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells. Implication of inflammation-associated carcinogenesis and tumor progression Am. J. Pathol. 163 2003 2221 2232
16. F. Okada, K. Nakai, T. Kobayashi, T. Shibata, S. Tagami, Y. Kawakami, T. Kitazawa, R. Kominami, S. Yoshimura, K. Suzuki, N. Taniguchi, O. Inanami, M. Kuwabara, H. Kishida, D. Nakae, Y. Konishi, T. Moriuchi, and M. Hosokawa Inflammatory cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells Br. J. Cancer 79 1999 377 385
17. F. Okada, M. Hosokawa, J. Hasegawa, Y. Kuramitsu, K. Nakai, L. Yuan, H. Lao, H. Kobayashi, and N. Takeichi Enhancement of in vitro prostaglandin E2 production by mouse fibrosarcoma cells after co-culture with various anti-tumor effector cells Br. J. Cancer 70 1994 233 238
18. M. Ishikawa, F. Okada, J.-I. Hamada, M. Hosokawa, and H. Kobayashi Changes in the tumorigenic and metastatic properties of tumor cells treated with quercetin or 5-azacytidine Int. J. Cancer 39 1987 338 342
19. M.J. Griffiths, M. Messent, R.J. MacAllister, and T.W. Evans Aminoguanidine selectively inhibits inducible nitric oxide synthase Br. J. Pharmacol. 110 1993 963 968
20. L.J. Mordan, T.S. Burnett, L.X. Zhang, J. Tom, and R.V. Cooney Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts Carcinogenesis 14 1993 1555 1559
21. S. Calmels, P. Hainaut, and H. Ohshima Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein Cancer Res. 57 1997 3365 3369
22. C.S. Cobbs, M. Samanta, L.E. Harkins, G.Y. Gillespie, B.A. Merrick, and L.A. MacMillan-Crow Arch. Biochem. Biophys. 394 2001 167 172
23. H.M. Lander, J.S. Ogiste, S.F. Pearce, R. Levi, and A. Novogrodsky Nitric oxide-stimulated guanine nucleotide exchange on p21ras J. Biol. Chem. 270 1995 7017 7020
24. A. Hmadcha, F.J. Bedoya, F. Sobrino, and E. Pintado Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production J. Exp. Med. 190 1999 1595 1604
25. M. Jaiswal, N.F. LaRusso, N. Nishioka, Y. Nakabeppu, and G.J. Gores Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide Cancer Res. 61 2001 6388 6393
26. J. Laval, and D.A. Wink Inhibition by nitric oxide of the repair protein O6-methylguanine-DNA-methyltransferase Carcinogenesis 15 1994 443 447
27. J.B. Mannick, K. Asano, K. Izumi, E. Kieff, and J.S. Stamler Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation Cell 79 1994 1137 1146
28. Y.M. Kim, R.V. Talanian, and T.R. Billiar Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms J. Biol. Chem. 272 1997 31138 31148
29. M. Vasa, K. Breitschopf, A.M. Zeiher, and S. Dimmeler Nitric oxide activates telomerase and delays endothelial cell senescence Circ. Res. 87 2000 540 542
30. G. Speit, C. Dennog, U. Eichhorn, A. Rothfuss, and B. Kaina Induction of heme oxygenase-1 and adaptive protection against the induction of DNA damage after hyperbaric oxygen treatment Carcinogenesis 21 2000 1795 1799
31. T. Okamoto, T. Akaike, T. Sawa, Y. Miyamoto, A. vander Vliet, and H. Maeda Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation J. Biol. Chem. 276 2001 29596 29602
32. D.C. Goodwin, L.M. Landino, and L.J. Marnett Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis FASEB J. 13 1999 1121 1136
33. J.M. Mei, N.G. Hord, D.F. Winterstein, S.P. Donald, and J.M. Phang Expression of prostaglandin endoperoxide H synthase-2 induced by nitric oxide in conditionally immortalized murine colonic epithelial cells FASEB J. 14 2000 1188 1201
34. P. Lejeune, P. Lagadec, N. Onier, D. Pinard, H. Ohshima, and J.F. Jeannin Nitric oxide involvement in tumor-induced immunosuppression J. Immunol. 152 1994 5077 5083
35. P. Hegardt, B. Widegren, and H.O. Sjogren Nitric-oxide-dependent systemic immunosuppression in animals with progressively growing malignant gliomas Cell Immunol. 200 2000 116 127
36. K. Chin, Y. Kurashima, T. Ogura, H. Tajiri, S. Yoshida, and H. Esumi Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells Oncogene 15 1997 437 442
37. G. Garcia-Cardena, and J. Folkman Is there a role of nitric oxide in tumor angiogenesis? J. Natl. Cancer Inst. 90 1998 560 561
38. P.M. Bauer, G.M. Buga, and L.J. Ignarro Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide Proc. Natl. Acad. Sci. USA 98 2001 12802 12807
39. K. Xie, S. Huang, Z. Dong, S.H. Juang, M. Gutman, Q.W. Xie, C. Nathan, and I.J. Fidler Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates gene metastasis in K-1735 murine melanoma cells J. Exp. Med. 181 1995 1333 1343
40. S.P. Hussain, G.E. Trivers, L.J. Hofseth, P. He, I. Shaikh, L.E. Mechanic, S. Doja, W. Jiang, J. Subleski, L. Shorts, D. Haines, V.E. Laubach, R.H. Wiltrout, D. Djurickovic, and C.C. Harris Nitric oxide, a mediator of inflammation, suppresses tumorigenesis Cancer Res. 64 2004 6849 6853
41. S. Ambs, S.P. Hussain, and C.C. Harris Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression FASEB J. 11 1997 443 448
42. W. Niedbala, X.Q. Wei, C. Campbell, D. Thomson, M. Komai-Koma, and F.Y. Liew Nitric oxide preferentially induces type 1 T-cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP Proc. Natl. Acad. Sci. USA 99 2002 16186 16191
43. P.K. Lala, and C. Chakraborty Role of nitric oxide in carcinogenesis and tumour progression Lancet Oncol. 3 2001 149 156
44. P. Nicotera, E. Bonfoco, and B. Brune Mechanisms for nitric oxide-induced cell death: involvement of apoptosis Adv. Neuroimmunol. 5 1997 411 420
45. J.B. Mannick, X.Q. Miao, and J.S. Stamler Nitric oxide inhibits Fas-induced apoptosis J. Biol. Chem. 272 1997 24125 24128
46. F. Okada, and J. Fujii Prevention of tumor progression as the ultimate goal of cancer therapy Cancer Ther. 3 2005 219 226
47. A.R. Amin, M.G. Attur, G.D. Thakker, P.D. Patel, P.R. Vyas, R.N. Patel, I.R. Patel, and S.B. Abramson A novel mechanism of action of tetracyclines: effects on nitric oxide synthases Proc. Natl. Acad. Sci. USA 93 1996 14014 14019
48. A.R. Amin, R.N. Patel, G.D. Thakker, C.J. Lowenstein, M.G. Attur, and S.B. Abramson Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines FEBS Lett. 410 1997 259 264
49. M. Whiteman, and B. Halliwell Prevention of peroxynitrite-dependent tyrosine nitration and inactivation of alpha1-antiproteinase by antibiotics Free Radic. Res. 26 1997 49 56
50. P.J. Thornally Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts Arch. Biochem. Biophys. 419 2003 31 40